Compare DSWL & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSWL | HYFT |
|---|---|---|
| Founded | 1987 | 1983 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.4M | 56.5M |
| IPO Year | 2000 | 2017 |
| Metric | DSWL | HYFT |
|---|---|---|
| Price | $2.88 | $1.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.33 |
| AVG Volume (30 Days) | 5.5K | ★ 296.1K |
| Earning Date | 11-16-2026 | 12-14-2026 |
| Dividend Yield | ★ 7.02% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.86 |
| Revenue Next Year | N/A | $22.94 |
| P/E Ratio | $4.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.80 | $0.99 |
| 52 Week High | $4.06 | $3.00 |
| Indicator | DSWL | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 32.51 | 36.23 |
| Support Level | N/A | $1.03 |
| Resistance Level | $3.48 | $1.50 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 5.02 | 11.81 |
Deswell Industries Inc comprise the manufacturing and sales of injection-molded plastic parts and components and electronic products assembling. The manufacturing activities are subcontracted to operating in the Macao Special Administrative Region (Macao) of the PRC. It produce a wide variety of plastic parts and components that are used in the manufacture of consumer and industrial products, using different plastic injection technologies, such as film injection, integrated injection and insert injection. It has two segments: plastic injection molding and electronic products assembling. It has generates majority of profit from Electronic Segment. It has presence in China, United States, Europe, Hong Kong, United Kingdom, Canada, and Others of which majority of sales is from China.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.